Inhibition of α-Secretase by Zinc Metalloproteinase Inhibitors
S Parvathy1, A J Turner, N M Hooper
1School of Biochemistry and Molecular Biology, University of Leeds, Leeds, UK.
Methods in Molecular Medicine
|February 15, 2011
Summary
Researchers identified low molecular weight inhibitors for alpha-secretase, a key enzyme in processing amyloid precursor protein (APP). This finding is crucial for developing Alzheimer's disease therapeutics by modulating APP cleavage pathways.
Area of Science:
- Neuroscience
- Biochemistry
- Molecular Biology
Background:
- Amyloid precursor protein (APP) processing involves α-, β-, and γ-secretases, determining amyloidogenic or non-amyloidogenic pathways.
- The amyloidogenic pathway generates β-amyloid (Aβ) peptides, implicated in Alzheimer's disease pathology.
- The non-amyloidogenic pathway, involving α-secretase, prevents Aβ deposition and releases neuroprotective sAPPα.
Purpose of the Study:
- To identify and characterize secretases involved in APP processing.
- To investigate potential therapeutic strategies for Alzheimer's disease by targeting APP secretases.
- To explore the effects of protease inhibitors on α- and β-secretase activities.
Main Methods:
- Investigated the impact of various protease inhibitors on α- and β-secretase activities.
- Focused on identifying specific inhibitors for APP secretases.
Main Results:
- Identified low molecular weight inhibitors specifically targeting α-secretase.
- Demonstrated the feasibility of modulating APP processing through secretase inhibition.
Conclusions:
- Low molecular weight α-secretase inhibitors represent a promising therapeutic avenue for Alzheimer's disease.
- Targeting the balance between APP processing pathways offers potential for disease intervention.
- Further research into APP secretase inhibitors is warranted for drug development.
Related Concept Videos
01:30Enzyme Inhibition
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
01:30Ligand-Gated Ion Channel Receptor: Gating Mechanism
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:19Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
00:46Feedback Inhibition
Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
01:19Masking and Demasking Agents
EDTA titrations may necessitate masking and demasking agents to temporarily protect a particular metal ion in a mixture from the EDTA reaction. These agents facilitate the sequential analysis of the metal ions by forming stable complexes with some—but not all—metal ions during certain steps.
There are many masking agents, such as cyanide, fluoride, triethanolamine, thiourea, and 2,3-bis(sulfanyl)propan-1-ol (formerly 2,3-dimercapto-1-propanol), with the masking agent chosen based on the metal...
There are many masking agents, such as cyanide, fluoride, triethanolamine, thiourea, and 2,3-bis(sulfanyl)propan-1-ol (formerly 2,3-dimercapto-1-propanol), with the masking agent chosen based on the metal...